logo

Corvus Pharmaceuticals, Inc. (CRVS)



Trade CRVS now with
  Date
  Headline
6/2/2019 1:00:30 PM Corvus Pharma Presents Initial CPI-006 Phase 1/1b Clinical Data At 2019 ASCO Annual Meeting
5/13/2019 6:29:37 AM Wedbush Is Lowering Corvus Pharmaceuticals, Inc. (CRVS) FY19 Estimate To -1.76 From -1.72
5/13/2019 6:28:27 AM Wedbush Is Cutting Corvus Pharmaceuticals, Inc. (CRVS) Q4 19 Estimate To -0.48 From -0.47
5/13/2019 6:28:14 AM Wedbush Is Cutting Corvus Pharmaceuticals, Inc. (CRVS) Q3 19 Estimate To -0.45 From -0.44
5/13/2019 6:28:01 AM Wedbush Is Cutting Corvus Pharmaceuticals, Inc. (CRVS) Q2 19 Estimate To -0.42 From -0.41
1/28/2019 4:09:21 PM Corvus Pharmaceuticals Appoints Linda Grais To Board Of Directors
11/5/2018 6:52:36 AM Wedbush Is Raising Corvus Pharmaceuticals, Inc. (CRVS) FY18 Estimate To -1.81 From -2.02
11/5/2018 6:52:22 AM Wedbush Is Raising Corvus Pharmaceuticals, Inc. (CRVS) Q4 18 Estimate To -0.41 From -0.52
8/8/2018 8:58:44 AM Wedbush Is Raising Corvus Pharmaceuticals, Inc. (CRVS) FY18 Estimate To -2.02 From -2.61
8/8/2018 8:57:51 AM Wedbush Is Increasing Corvus Pharmaceuticals, Inc. (CRVS) Q4 18 Estimate To -0.52 From -0.73
8/8/2018 8:57:29 AM Wedbush Is Increasing Corvus Pharmaceuticals, Inc. (CRVS) Q3 18 Estimate To -0.47 From -0.66
6/28/2018 8:39:07 AM Corvus Reports Publication Of Preclinical Study Results Demonstrating CPI-444 Antitumor Activity
5/7/2018 4:43:07 PM Wedbush Is Raising Corvus Pharmaceuticals, Inc. (CRVS) FY18 Estimate To -2.61 From -3.09
5/7/2018 4:42:42 PM Wedbush Is Raising Corvus Pharmaceuticals, Inc. (CRVS) Q2 18 Estimate To -0.59 From -0.84
4/26/2018 8:38:06 AM Corvus Pharma Begins Phase 1/1b Clinical Trial Of CPI-006 In Patients With Advanced Cancer
  
 
>